ClinicalTrials.govpublic full text
Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
chronic kidney disease, hyperparathyroidism, secondary, vitamin d deficiency, parathyroid diseases, renal insufficiency, kidney failure, chronic, vitamin d, hyperparathyroidism, kidney diseases, kidney failure, renal insufficiency, chronic, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 911377
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.